Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05Feb 01, 2023
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06Oct 11, 2022
Expanded Capacity
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
WuXi STA
PR-M01-20-NI-010Jan 07, 2020
Oligonucleotides
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
Bill Jarvis; Brendan Nichols
CRB USA
PAP-Q4-18-CL-002Oct 26, 2018
Strategic Partnership
New Collaboration Targets the Development of Oligonucleotides
Nigel Walker
Nice Insight
PAO-M12-17-NI-002Dec 01, 2017